Medicare Enrolled

Dr. Daniel Nohra Revilla, DO

Neurology · Orlando, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
32 W GORE ST FL 3, Orlando, FL 32806
4073525434
In practice since 2015 (11 years)
NPI: 1114319191 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nohra Revilla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nohra Revilla? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Nohra Revilla

Dr. Daniel Nohra Revilla is a neurology in Orlando, FL, with 11 years in practice. Based on federal Medicare data, Dr. Nohra Revilla performed 7,757 Medicare services across 136 unique beneficiaries.

Between the years covered by Open Payments, Dr. Nohra Revilla received a total of $6,924 from 22 pharmaceutical and/or device companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Nohra Revilla is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice▲ Top 13% volume in FL$ $6,924 industry payments

Medicare Practice Summary

Medicare Utilization ↗
7,757
Medicare services
Top 13% in FL for neurology
136
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~705 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Botox injection, per unit7,600$5$18
Office visit, established patient (30-39 min)46$87$331
Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face40$118$469
New patient office visit (45-59 min)27$122$498
Office visit, established patient (20-29 min)17$61$232
Office visit, established patient, complex (40-54 min)16$140$462
Telephone medical discussion with physician, 11-20 minutes11$70$230
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$6,924
Total received (2018-2024)
Avg $989/year across 7 years
Top 34% in FL for neurology
22
Companies
459
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,924 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,057
2023
$1,393
2022
$1,918
2021
$1,617
2020
$529
2019
$252
2018
$158

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,797
PFIZER INC.
$777
Lilly USA, LLC
$760
Biohaven Pharmaceutical Holding Company Ltd.
$494
Lundbeck LLC
$493
Amgen Inc.
$487
Biohaven Pharmaceuticals, Inc.
$474
AbbVie Inc.
$383
Teva Pharmaceuticals USA, Inc.
$345
Allergan, Inc.
$313
US WorldMeds, LLC
$245
UPSHER-SMITH LABORATORIES LLC
$96
Allergan Inc.
$74
Novartis Pharmaceuticals Corporation
$37
Boston Scientific Corporation
$28
Curonix LLC
$27
Scilex Pharmaceuticals Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
SCILEX PHARMACEUTICALS INC.
$17
Assertio Therapeutics, Inc.
$15
Genentech USA, Inc.
$12
Zimmer Biomet Holdings, Inc.
$12
Top 3 companies account for 48.2% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · ANDEXXA · AUSTEDO · Aimovig · Austedo XR · BOTOX · Biomet SpinalPak · CAMBIA · COMIRNATY · ELIQUIS · EMGALITY · NURTEC ODT · OCREVUS · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · QULIPTA · REYVOW · TOSYMRA · UBRELVY · VYEPTI · Xadago · ZEMBRACE SYMTOUCH · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $89 per 100 Medicare services performed
Looking for a neurology in Orlando?
Compare neurologys in the Orlando area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
92
Per 100K population
6.4
County median income
$77,011
Nearest hospital
ORLANDO HEALTH
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Nohra Revilla is a mixed practice specialist, with above-average Medicare volume (top 13% in FL), and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Nohra Revilla experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Nohra Revilla performed 7,600 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nohra Revilla receive payments from pharmaceutical companies?
Yes. Dr. Nohra Revilla received a total of $6,924 from 22 companies across 459 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nohra Revilla's costs compare to other neurologys in Orlando?
Dr. Nohra Revilla's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nohra Revilla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →